Lumexa Imaging Holdings, Inc. Common Stock (LMRI) financial statements and ratios from SEC XBRL: revenue $948.87M (latest fiscal year), net margin -9.9%, revenue growth 3.1% YoY, P/E 656.4. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $948.87M |
| Net Margin | -9.9% |
| Return on Equity | 0.3% |
| Debt / Equity | 1.38 |
| Current Ratio | 1.40 |
| Net Debt / EBITDA | 26.6 |
| Interest Coverage | 1.2 |
| Revenue Growth (YoY) | 3.1% |
| EPS Growth (YoY) | -118.2% |
| FCF Growth (YoY) | -84.1% |
| P/E Ratio | 656.4 |
| EV / EBITDA | 65.0 |
| Price / Book | 1.88 |
| Price / Sales | 4.46 |
| FCF Yield | -0.2% |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
LMRI overview · LMRI earnings · LMRI KPIs · LMRI documents · LMRI ownership · LMRI peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.